BioVentrix Announces Appointment of Accredited Public Company Director, Raymond W. Cohen, to its Board of Directors
SAN RAMON, Calif. – August 12, 2020 – BioVentrix, Inc., [...]
SAN RAMON, Calif. – August 12, 2020 – BioVentrix, Inc., [...]
Erstmals in Deutschland vorgestelltDie anhaltende infarktbedingte Herzschwäche besitzt weltweit eine [...]
SAN RAMON, Calif. — March 9, 2020 — BioVentrix, Inc., [...]
San Ramon, Kalifornien – 4. März 2020 – BioVentrix, Inc., [...]
REVIVE-HF seeks to demonstrate superiority of the Revivent TC System [...]
SAN RAMON, Calif. – February 18, 2020 – BioVentrix, Inc., [...]
Für Herzinfarkt-Patienten ist die innovative LIVE™-Therapie (Less Invasive Ventricular Enhancement) [...]
San Ramon, CA – February 6, 2020 – Bioventrix, Inc., [...]
San Ramon, Kalifornien – 22. Januar 2020 – BioVentrix, Inc., [...]
SAN RAMON, Calif. – January 22, 2020 – BioVentrix, Inc., [...]